CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cytokines. Limited evidence exists on the effectiveness of bilirubin adsorption by the hydrophobic styrenic resin, the distinctive part of CPFA. The aim of this study is to validate CPFA effectiveness in liver detoxification.
Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study) / Donati, Gabriele; Angeletti, Andrea; Gasperoni, Lorenzo; Piscaglia, Fabio; Croci Chiocchini, Anna Laura; Scrivo, Anna; Natali, Teresa; Ullo, Ines; Guglielmo, Chiara; Simoni, Patrizia; Mancini, Rita; Bolondi, Luigi; La Manna, Gaetano. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1724-6059. - ELETTRONICO. - 34:1(2021), pp. 77-88. [10.1007/s40620-020-00799-w]
Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study)
Donati, Gabriele;Angeletti, Andrea;Gasperoni, Lorenzo;Piscaglia, Fabio;Croci Chiocchini, Anna Laura;Scrivo, Anna;Natali, Teresa;Ullo, Ines;Guglielmo, Chiara;Simoni, Patrizia;Bolondi, Luigi;La Manna, Gaetano
2021
Abstract
CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cytokines. Limited evidence exists on the effectiveness of bilirubin adsorption by the hydrophobic styrenic resin, the distinctive part of CPFA. The aim of this study is to validate CPFA effectiveness in liver detoxification.| File | Dimensione | Formato | |
|---|---|---|---|
|
Donati2021_Article_DetoxificationOfBilirubinAndBi.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
